Compare MHD & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MHD | IRMD |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 910.4M |
| IPO Year | N/A | 2014 |
| Metric | MHD | IRMD |
|---|---|---|
| Price | $11.71 | $97.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $72.00 |
| AVG Volume (30 Days) | ★ 124.9K | 81.0K |
| Earning Date | 01-01-0001 | 02-12-2026 |
| Dividend Yield | ★ 4.16% | 0.70% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $80,511,268.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | N/A | $10.15 |
| P/E Ratio | ★ N/A | $59.24 |
| Revenue Growth | N/A | ★ 12.91 |
| 52 Week Low | $9.92 | $47.48 |
| 52 Week High | $12.18 | $98.53 |
| Indicator | MHD | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 68.33 |
| Support Level | $11.68 | $90.92 |
| Resistance Level | $11.68 | $98.53 |
| Average True Range (ATR) | 0.09 | 2.32 |
| MACD | -0.00 | -0.37 |
| Stochastic Oscillator | 71.43 | 92.77 |
Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.